PWMAI
DMAC icon

PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s DiaMedica Therapeutics DMAC Stock Holding History

PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-400
Closed -$2.71K – 555
2026
Q1 		$2.71K Buy
+400
New +$3.17K ﹤0.01% 459

Other funds holding DMAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MW
Members Wealth Media, Pennsylvania $182M AUM 15.09% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $3.25B AUM 41% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
CFP
Catalyst Financial Partners Boston, Massachusetts $1.01B AUM 36.54% 1-Year Est. Return

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s DMAC Position: Q2 2026 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold out of DiaMedica Therapeutics (DMAC) in Q2 2026, closing a stake of 400 shares — an estimated $2.71K sold.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in DMAC in Q1 2026 and held it in 1 quarter. The position peaked at $2.71K in Q1 2026. 30 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. reported no remaining DiaMedica Therapeutics position as of Q2 2026 after selling out during the quarter.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold 400 DiaMedica Therapeutics shares in Q2 2026, an estimated $2.71K.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in DiaMedica Therapeutics in Q1 2026 and held it in 1 quarter.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s DiaMedica Therapeutics position peaked at $2.71K in Q1 2026.
  • 30 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q2 2026, filed 7 Aug 2026.